Sage Therapeutics has announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the FDA. This development plan is intended to support a potential filing for approval of SAGE-217 in the U.S. for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). “Sage is excited to receive feedback from the […]

The Biotechnology Innovation Organization (BIO) has announced the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was instrumental in transforming Boston into a thriving hub of life science research, development and innovation. The award was presented yesterday in Boston at the 2018 BIO International Convention to Dr. Sue […]

In October 2017, the NIH and 11 leading biopharmaceutical companies launched PACT (the Partnership for Accelerating Cancer Therapies), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot.  PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers of disease and treatment response — […]

The Biotechnology Innovation Organization (BIO) has presented Governor Charlie Baker with its 2018 Governor of the Year award in recognition of his leadership and commitment to strengthening the bioscience industry within Massachusetts. Governor Baker received the award in conjunction with the 2018 BIO International Convention being held in Boston this week. “The Commonwealth’s life sciences sector is successful […]